5551 - 5575 of 8826 Results
Title
Year
-
OPENTitle: Safety, tolerability and pharmacokinetics of the oligomer modulator anle138b with exposure levels sufficient for therapeutic efficacy in a murine Parkinson model: A randomised, double-blind, placebo-controlled phase 1a trialJournal Name: eBioMedicinePublisher: Elsevier BVVol: 80Issue #:Start Page: 104021End Page: 104021Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.ebiom.2022.104021Best OA location URL: http://www.thelancet.com/article/S2352396422002055/pdfCitation Count: 81
-
OPENTitle: Whole genome sequencing identifies candidate genes for familial essential tremor and reveals biological pathways implicated in essential tremor aetiologyJournal Name: eBioMedicinePublisher: Elsevier BVVol: 85Issue #:Start Page: 104290End Page: 104290Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ebiom.2022.104290Best OA location URL: http://www.thelancet.com/article/S2352396422004728/pdfCitation Count: 31
-
OPENTitle: Tailoring Motor Fluctuation Treatment: Beyond Levodopa Dose AdjustmentJournal Name: European Medical JournalPublisher: European Medical GroupVol:Issue #:Start Page: 20End Page: 27Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.33590/emj/10022165Best OA location URL: https://www.emjreviews.com/wp-content/uploads/2022/12/Tailoring-Motor-Fluctuation-Treatment-Beyond-Levodopa-Dose-Adjustment-1.pdfCitation Count: 1
-
OPENTitle: Botulinum Toxin in the Treatment of Cervical Dystonia: Evidence-Based ReviewJournal Name: DystoniaPublisher: Frontiers Media SAVol: 1Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/dyst.2022.10655Best OA location URL: https://www.frontierspartnerships.org/articles/10.3389/dyst.2022.10655/pdfCitation Count: 7
-
OPENTitle: Tele-Yoga for the Management of Cervical Dystonia: A Safety and Feasibility TrialJournal Name: DystoniaPublisher: Frontiers Media SAVol: 1Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/dyst.2021.10015Best OA location URL: https://www.frontierspartnerships.org/articles/10.3389/dyst.2021.10015/pdfCitation Count: 0
-
OPENTitle: The Role of Alpha-Synuclein Autoantibodies in the Induction of Brain Inflammation and Neurodegeneration in Aged HumansJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page: 72End Page: 75Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.902191Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2022.902191/pdfCitation Count: 8
- Autoradiographic labelling of 5-HT3 receptors in the hemi-parkinsonian rat brain2021RESTRICTEDTitle: Autoradiographic labelling of 5-HT3 receptors in the hemi-parkinsonian rat brainJournal Name: Neuroscience ResearchPublisher: Elsevier BVVol: 177Issue #:Start Page: 135End Page: 144Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neures.2021.12.004Citation Count: 3
- Mild and direct 18F radiofluorination of tetrazines through sulfonium salt precursors2022RESTRICTEDTitle: Mild and direct 18F radiofluorination of tetrazines through sulfonium salt precursorsJournal Name: Nuclear Medicine and BiologyPublisher: Elsevier BVVol: 108-109Issue #:Start Page: S88End Page: S89Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s0969-8051(22)00209-8Citation Count: 0
- Alternative protective group strategy for the radiosynthesis of Flortaucipir 18F2022RESTRICTEDTitle: Alternative protective group strategy for the radiosynthesis of Flortaucipir 18FJournal Name: Nuclear Medicine and BiologyPublisher: Elsevier BVVol: 108-109Issue #:Start Page: S88End Page: S88Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s0969-8051(22)00208-6Citation Count: 0
- Optimizing the reaction conditions for the GMP production of [18F]ACI-12589, a promising candidate in the development as a PET tracer targeting α-synuclein2022RESTRICTEDTitle: Optimizing the reaction conditions for the GMP production of [18F]ACI-12589, a promising candidate in the development as a PET tracer targeting α-synucleinJournal Name: Nuclear Medicine and BiologyPublisher: Elsevier BVVol: 108-109Issue #:Start Page: S87End Page: S88Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s0969-8051(22)00207-4Citation Count: 0
-
OPENTitle: Necessity and feasibility of remote tele-programming of deep brain stimulation systems in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 96Issue #:Start Page: 38End Page: 42Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.01.017Best OA location URL: https://doi.org/10.1016/j.parkreldis.2022.01.017Citation Count: 32
-
OPENTitle: Immediate-release/extended-release amantadine (OS320) to treat Parkinson's disease with levodopa-induced dyskinesia: Analysis of the randomized, controlled ALLAY-LID studiesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 96Issue #:Start Page: 65End Page: 73Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.01.022Best OA location URL: https://doi.org/10.1016/j.parkreldis.2022.01.022Citation Count: 20
- Perivascular space in Parkinson's disease: Association with CSF amyloid/tau and cognitive decline2022RESTRICTEDTitle: Perivascular space in Parkinson's disease: Association with CSF amyloid/tau and cognitive declineJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 95Issue #:Start Page: 70End Page: 76Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.01.002Citation Count: 39
-
OPENTitle: Stimulation of the pedunculopontine and cuneiform nuclei for freezing of gait and falls in Parkinson disease: Cross-over single-blinded study and long-term follow-upJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 96Issue #:Start Page: 13End Page: 17Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.01.010Best OA location URL: https://hal.sorbonne-universite.fr/hal-03603648Citation Count: 18
- A randomized clinical trial of burst vs. spaced physical therapy for Parkinsons disease2022RESTRICTEDTitle: A randomized clinical trial of burst vs. spaced physical therapy for Parkinsons diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 97Issue #:Start Page: 57End Page: 62Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.02.021Citation Count: 12
-
RESTRICTEDTitle: Polygenic burden of Parkinson's disease risk stratifies the prognosis of isolated rapid-eye-movement disorder: A preliminary observational studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 96Issue #:Start Page: 52End Page: 56Publication Date:Open Access(OA) Status: RESTRICTEDLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.02.005Best OA location URL: https://doi.org/10.1016/j.parkreldis.2022.02.005Citation Count: 3
- Subacute tremor and ataxia: Diligence in pursuit of a diagnosis2022RESTRICTEDTitle: Subacute tremor and ataxia: Diligence in pursuit of a diagnosisJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 104Issue #:Start Page: 129End Page: 131Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.05.016Citation Count: 1
- Association between probable REM sleep behavior disorder and increased dermal alpha-synuclein deposition in Parkinson's disease2022RESTRICTEDTitle: Association between probable REM sleep behavior disorder and increased dermal alpha-synuclein deposition in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 99Issue #:Start Page: 58End Page: 61Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.05.010Citation Count: 19
-
OPENTitle: Characterization and diagnostic potential of R2* in early-stage progressive supranuclear palsy variantsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 101Issue #:Start Page: 43End Page: 48Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.021Best OA location URL: http://www.prd-journal.com/article/S1353802022002176/pdfCitation Count: 11
- Smoking is associated with age at disease onset in Parkinson's disease2022RESTRICTEDTitle: Smoking is associated with age at disease onset in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 97Issue #:Start Page: 79End Page: 83Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.03.005Citation Count: 6
- What the VaP? The meaning of “vascular parkinsonism”2021RESTRICTEDTitle: What the VaP? The meaning of “vascular parkinsonism”Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 94Issue #:Start Page: 132End Page: 134Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.12.008Citation Count: 10
- The effect of limb selection methods on gait analysis in Parkinson's disease2022RESTRICTEDTitle: The effect of limb selection methods on gait analysis in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 104Issue #:Start Page: 81End Page: 84Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.10.013Citation Count: 2
- Serial olfactory testing for the diagnosis of prodromal Parkinson's disease in the PARS study2022RESTRICTEDTitle: Serial olfactory testing for the diagnosis of prodromal Parkinson's disease in the PARS studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 104Issue #:Start Page: 15End Page: 20Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.09.007Citation Count: 11
-
OPENTitle: Physical activity and exercise outcomes in Huntington's disease (PACE-HD): results of a 12-month trial-within-cohort feasibility study of a physical activity intervention in people with Huntington's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 101Issue #:Start Page: 75End Page: 89Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.013Best OA location URL: http://www.prd-journal.com/article/S1353802022002048/pdfCitation Count: 22
- Relationships of self-reported and objective measures of sleep, sleepiness, and sleep quality in Parkinson's disease2022RESTRICTEDTitle: Relationships of self-reported and objective measures of sleep, sleepiness, and sleep quality in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 101Issue #:Start Page: 57End Page: 61Publication Date:Open Access(OA) Status: RESTRICTEDLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.009Citation Count: 10